RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug tested as potential leukemia fighter
Disease control CompletedThis study tested whether metformin, a common and inexpensive diabetes medication, could help control chronic lymphocytic leukemia (CLL). It involved 37 adults with either relapsed CLL or a specific genetic type of untreated CLL. The goal was to see if taking metformin could slow…
Matched conditions: RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for blood cancer patients: gentler transplants from family donors
Disease control CompletedThis study tested a less intense bone marrow transplant procedure for adults with various blood cancers who needed a transplant but did not have a fully matched donor. It used stem cells from a half-matched family member (like a parent, child, or sibling) after a milder pre-trans…
Matched conditions: RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC